Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 73Temozolomide 70Specimen Handling 49Radiotherapy 41Radiosurgery 31Radiation 26Cyclophosphamide 26Bevacizumab 26Nivolumab 23Biopsy 21pembrolizumab 20Carboplatin 16X-Rays 15Lomustine 14Ipilimumab 14fludarabine 12Vincristine 12Irinotecan 12Cisplatin 12Topotecan 11Surgical Procedures, Operative 11Blood Specimen Collection 11trametinib 9dinutuximab 9Immunoglobulin G 8Etoposide 8Doxorubicin 8AZD 6244 8lutetium Lu 177 dotatate 7fludarabine phosphate 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fluorine-18 × CNS × 90 days × Clear all
NCT05937776 2026-06-05

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

OHSU Knight Cancer Institute

Completed
4 enrolled
CNS

Glioma

NCT06474533 2026-04-03

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

University of California, San Francisco

Recruiting
199 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡